The American Society of Clinical Oncology (ASCO) is backing legislation (H.R. 1097) that would give the Food and Drug Administration (FDA) the authority to regulate tobacco products. The legislation explicitly states that nicotine(Drug information on nicotine) should be regulated as a drug, and tobacco products as drug delivery devices. The legislation also gives the FDA the authority to regulate tobacco product advertising and promotion. Reps. Greg Ganske (R-Iowa), John Dingell (D-Mich), and Henry Waxman (D-Calif) are the primary sponsors.
"We greatly appreciate the consistent leadership Reps. Ganske, Dingell, and Waxman provide on behalf of the federal regulation of tobacco products," said an ASCO statement. "Smoking accounts for at least 30% of all cancer deaths, is a major cause of heart disease, and is associated with conditions ranging from colds and gastric ulcers to chronic bronchitis, emphysema, and cerebrovascular disease."